Optimization of Drug Safety Profile in Inflammatory Bowel Disease Through a Personalized Approach

E-ISSN： 1873-5592|19|7|740-747

ISSN： 1389-4501

Source： Current Drug Targets, Vol.19, Iss.7, 2018-04, pp. : 740-747

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy

By Connell W. Miller A.

Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. : 311-323

Adis International

Access to resources Recommend Favorite

Can Surgery for Inflammatory Bowel Disease be Personalized?

Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. : 798-804

Bentham Science Publishers

Access to resources Recommend Favorite

Phospholipid-Based Prodrugs for Drug Targeting in Inflammatory Bowel Disease: Computational Optimization and In-Vitro Correlation

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 23, 2016-07 ,pp. : 2543-2548

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety

Current Molecular Pharmacology, Vol. 3, Iss. 3, 2010-11 ,pp. : 145-152

Bentham Science Publishers

Access to resources Recommend Favorite

Thiopurines in Inflammatory Bowel Disease - The Role of Pharmacogenetics and Therapeutic Drug Monitoring

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-12 ,pp. : 285-300

Bentham Science Publishers

Access to resources Recommend Favorite